The Weight You’re Losing on Ozempic Isn’t Just Fat
Millions of people are taking GLP-1 drugs like Ozempic, Wegovy and Mounjaro and watching the scale drop. What most of them don’t realise is that a significant portion of what’s disappearing isn’t fat. It’s muscle.
Clinical trials of semaglutide show that lean body mass can account for up to 40–45% of total weight lost. On tirzepatide, around 34%. You might celebrate losing 15kg — not realising that 5 or 6 of those kilograms were muscle you needed.
This matters more than most people think.
Why losing muscle is a slow-motion health crisis
Muscle isn’t just for lifting things. It is your metabolic engine, your insulin regulator, your protection against falls and fractures, your longevity insurance.
Lose enough of it and your metabolism slows — making weight regain almost inevitable when you stop the drug. Your blood sugar regulation worsens. Your bones weaken. Your balance deteriorates. And after 40, the body already loses 3–8% of muscle mass per decade naturally. GLP-1-accelerated loss compounds a problem that was already working against you.
Sarcopenia — the clinical loss of muscle mass — affects over 45% of older adults and is directly linked to falls, hospitalisation, loss of independence, and premature death. Research published in Circulation confirms that older age and low baseline muscle mass significantly increase the risk of clinically meaningful sarcopenia during GLP-1 therapy.
A smaller body with less muscle is not a healthier body. It is a frailer one.
The fix the prescription doesn’t mention
Mass General Brigham researchers are clear: combining GLP-1 therapy with resistance training and adequate protein has the greatest benefit in preserving muscle and bone — significantly better than diet alone.
Patients who exercise consistently from the start of treatment have the best outcomes. Not cardio. Resistance training. The kind that signals to your body that the muscle it’s considering sacrificing is still needed.
The drug suppresses your appetite. Your body responds by looking for energy wherever it can find it. Strength training tells it: not here.
You need to build the body that lasts
The number on the scale is not the goal. Functional strength, metabolic health, and independence at 60, 70 and 80 — that is the goal.
If you’re on a GLP-1 drug and not doing resistance training, you are solving one problem while quietly creating another.
The good news: you don’t need hours in a gym. Research shows that even two structured strength sessions a week produce meaningful muscle preservation. At Threezero, our AI-guided Biocircuit delivers a complete full-body strength workout in 30 minutes — no experience needed, no intimidation, just the work your body actually requires right now.
The drug is a tool. Muscle is the foundation. Don’t lose both.
Threezero | Cape Quarter Lifestyle Village, De Waterkant, Cape Town | threezero.co.za
